- Home
- Publications
- Publication Search
- Publication Details
Title
Forty-Year Journey of Angiogenesis Translational Research
Authors
Keywords
-
Journal
Science Translational Medicine
Volume 3, Issue 114, Pages 114rv3-114rv3
Publisher
American Association for the Advancement of Science (AAAS)
Online
2011-12-22
DOI
10.1126/scitranslmed.3003149
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Glioblastoma Recurrence after Cediranib Therapy in Patients: Lack of "Rebound" Revascularization as Mode of Escape
- (2011) E. di Tomaso et al. CANCER RESEARCH
- Antiangiogenic cancer therapy: why do mouse and human patients respond in a different way to the same drug?
- (2011) Yihai Cao INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY
- RIBBON-1: Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Chemotherapy With or Without Bevacizumab for First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative, Locally Recurrent or Metastatic Breast Cancer
- (2011) Nicholas J. Robert et al. JOURNAL OF CLINICAL ONCOLOGY
- A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Paclitaxel-Carboplatin Alone or with Endostar for Advanced Non-small Cell Lung Cancer
- (2011) Baohui Han et al. Journal of Thoracic Oncology
- Molecular mechanisms and clinical applications of angiogenesis
- (2011) Peter Carmeliet et al. NATURE
- Mouse corneal lymphangiogenesis model
- (2011) Renhai Cao et al. Nature Protocols
- Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases
- (2011) Peter Carmeliet et al. NATURE REVIEWS DRUG DISCOVERY
- Antiangiogenic agents significantly improve survival in tumor-bearing mice by increasing tolerance to chemotherapy-induced toxicity
- (2011) D. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Carmustine Wafers (Gliadel) Plus Concomitant Temozolomide Therapy After Resection of Malignant Astrocytoma: Growing Evidence for Safety and Efficacy
- (2010) Matthew J. McGirt et al. ANNALS OF SURGICAL ONCOLOGY
- Angiogenesis: What can it offer for future medicine?
- (2010) Yihai Cao EXPERIMENTAL CELL RESEARCH
- The Anti-angiogenic Peptide, Loop 6, Binds Insulin-like Growth Factor-1 Receptor
- (2010) Cecilia A. Fernandez et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Adipose angiogenesis: quantitative methods to study microvessel growth, regression and remodeling in vivo
- (2010) Yuan Xue et al. Nature Protocols
- Off-tumor target—beneficial site for antiangiogenic cancer therapy?
- (2010) Yihai Cao Nature Reviews Clinical Oncology
- Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases
- (2010) Yihai Cao NATURE REVIEWS DRUG DISCOVERY
- First-line treatment of malignant glioma with carmustine implants followed by concomitant radiochemotherapy: a multicenter experience
- (2010) Hans Christoph Bock et al. NEUROSURGICAL REVIEW
- Optimizing the Delivery of Cancer Drugs That Block Angiogenesis
- (2010) Y. Cao et al. Science Translational Medicine
- Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
- (2009) Marta Pàez-Ribes et al. CANCER CELL
- Hypoxia-Independent Angiogenesis in Adipose Tissues during Cold Acclimation
- (2009) Yuan Xue et al. Cell Metabolism
- Phase I/II Trial of Metronomic Chemotherapy With Daily Dalteparin and Cyclophosphamide, Twice-Weekly Methotrexate, and Daily Prednisone As Therapy for Metastatic Breast Cancer Using Vascular Endothelial Growth Factor and Soluble Vascular Endothelial Growth Factor Receptor Levels As Markers of Response
- (2009) Nan Soon Wong et al. JOURNAL OF CLINICAL ONCOLOGY
- Combining radiation, immunotherapy, and antiangiogenesis agents in the management of cancer: the Three Musketeers or just another quixotic combination?
- (2009) Mitchell Kamrava et al. Molecular BioSystems
- Biomarkers of response and resistance to antiangiogenic therapy
- (2009) Rakesh K. Jain et al. Nature Reviews Clinical Oncology
- VEGFR1-mediated pericyte ablation links VEGF and PlGF to cancer-associated retinopathy
- (2009) R. Cao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Improvement of antiangiogenic cancer therapy by understanding the mechanisms of angiogenic factor interplay and drug resistance
- (2009) Yihai Cao et al. SEMINARS IN CANCER BIOLOGY
- Use of Gliadel (BCNU) Wafer in the Surgical Treatment of Malignant Glioma: A 10-Year Institutional Experience
- (2008) Frank J. Attenello et al. ANNALS OF SURGICAL ONCOLOGY
- Vascular Endothelial Growth Factor Mediated Decrease in Plasma Soluble Vascular Endothelial Growth Factor Receptor-2 Levels as a Surrogate Biomarker for Tumor Growth
- (2008) J. M.L. Ebos et al. CANCER RESEARCH
- Urinary Biomarkers Predict Brain Tumor Presence and Response to Therapy
- (2008) E. R. Smith et al. CLINICAL CANCER RESEARCH
- Radiation therapy and biological compounds for consolidation therapy in advanced ovarian cancer
- (2008) A. AURANEN et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Association of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor-2 Genetic Polymorphisms With Outcome in a Trial of Paclitaxel Compared With Paclitaxel Plus Bevacizumab in Advanced Breast Cancer: ECOG 2100
- (2008) Bryan P. Schneider et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma
- (2008) Teri N. Kreisl et al. JOURNAL OF CLINICAL ONCOLOGY
- Transdermal drug delivery
- (2008) Mark R Prausnitz et al. NATURE BIOTECHNOLOGY
- Community corner
- (2008) NATURE MEDICINE
- Tumor Angiogenesis
- (2008) Robert S. Kerbel NEW ENGLAND JOURNAL OF MEDICINE
- Synergy Between Cetuximab and Chemotherapy in Tumors of the Gastrointestinal Tract
- (2008) R. L. Mahtani et al. ONCOLOGIST
- Anti-VEGF agents confer survival advantages to tumor-bearing mice by improving cancer-associated systemic syndrome
- (2008) Y. Xue et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- New frontiers in nanotechnology for cancer treatment
- (2008) Frank Alexis et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now